The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia1
暂无分享,去创建一个
[1] Nikolaos M. Nikolaidis,et al. Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation* , 2005, Journal of Biological Chemistry.
[2] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[3] E. Lenkiewicz,et al. Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.
[4] Jack A. Elias,et al. Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation , 2004, Science.
[5] J. Lötvall,et al. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. , 2004, The Journal of allergy and clinical immunology.
[6] D. Voehringer,et al. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.
[7] Paige Lacy,et al. Eosinophil function in allergic inflammation: From bone marrow to tissue response , 2004, Current allergy and asthma reports.
[8] S. Wenzel. Mechanisms of severe asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[9] P. Foster,et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. , 2003, The Journal of allergy and clinical immunology.
[10] C. Hogaboam,et al. Chemokine Receptors in Asthma: Searching for the Correct Immune Targets , 2003, The Journal of Immunology.
[11] Qutayba Hamid,et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.
[12] A. F. Stewart,et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.
[13] B. Vargaftig,et al. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. , 2003, American journal of respiratory cell and molecular biology.
[14] P. Foster,et al. Chemokines in asthma: cooperative interaction between chemokines and IL-13. , 2003, The Journal of allergy and clinical immunology.
[15] Larry Borish,et al. 5. Genetics of hypersensitivity. , 2003, The Journal of allergy and clinical immunology.
[16] A. Kay,et al. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.
[17] R. Geha,et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.
[18] S. Rankin,et al. Eotaxin-2 Generation Is Differentially Regulated by Lipopolysaccharide and IL-4 in Monocytes and Macrophages1 , 2002, The Journal of Immunology.
[19] D. Friend,et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Luster. Antichemokine immunotherapy for allergic diseases , 2001, Current opinion in allergy and clinical immunology.
[21] J. Denburg,et al. Allergen‐induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis , 2001, Immunology.
[22] P. Foster,et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. , 2001, The Journal of allergy and clinical immunology.
[23] M. Rothenberg,et al. Eosinophil levels in mice are significantly higher in small blood vessels than in large blood vessels. , 2001, The Journal of allergy and clinical immunology.
[24] K. Kubo,et al. Chemotaxis of Human CD4+ Eosinophils , 2001, International Archives of Allergy and Immunology.
[25] R. Breuer,et al. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. , 2001, American journal of respiratory cell and molecular biology.
[26] M. Rothenberg,et al. Interleukin-5-mediated Allergic Airway Inflammation Inhibits the Human Surfactant Protein C Promoter in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[27] F. Annunziato,et al. Expression of the Chemokine Receptor CCR3 on Human Mast Cells , 2001, International Archives of Allergy and Immunology.
[28] G. Yancopoulos,et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. , 2001, Developmental biology.
[29] D. Broide,et al. Eosinophil trafficking to sites of allergic inflammation , 2001, Immunological reviews.
[30] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[31] F. Finkelman,et al. Murine Eotaxin-2: A Constitutive Eosinophil Chemokine Induced by Allergen Challenge and IL-4 Overexpression1 , 2000, The Journal of Immunology.
[32] G. Gleich. Mechanisms of eosinophil-associated inflammation. , 2000, The Journal of allergy and clinical immunology.
[33] P. Foster,et al. The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1 , 2000, The Journal of Immunology.
[34] P. Askenase,et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (mono , 1999, Journal of immunology.
[35] T. Nishi,et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. , 1999, Journal of immunology.
[36] D. Friend,et al. Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Mackay,et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.
[38] H. Sarau,et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils , 1997, Journal of leukocyte biology.
[39] R. Strieter,et al. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. , 1997, Journal of immunology.
[40] R. Gentz,et al. Molecular and Functional Characterization of Two Novel Human C-C Chemokines as Inhibitors of Two Distinct Classes of Myeloid Progenitors , 1997, The Journal of experimental medicine.
[41] M. Isobe,et al. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. , 1997, Internal medicine.
[42] P. Foster,et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.
[43] P. Leder,et al. Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.
[44] T. Springer,et al. Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Friend,et al. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype , 1996, The Journal of cell biology.
[46] J. Demartino,et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.
[47] P. Foster,et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.
[48] T. Williams,et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.
[49] J. Schröder,et al. 5-Oxo-eicosanoids Are Potent Eosinophil Chemotactic Factors. , 1995, The Journal of Biological Chemistry.
[50] P. Leder,et al. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung , 1995, The Journal of experimental medicine.
[51] P. Swiatek,et al. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. , 1993, Genes & development.
[52] J. Fehr,et al. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. , 1992, Journal of immunology.
[53] L. Fedorov,et al. A comparison of the germline potential of differently aged ES cell lines and their transfected descendants , 2004, Transgenic Research.
[54] S. Rankin,et al. Eotaxin and eosinophil recruitment: implications for human disease. , 2000, Molecular medicine today.
[55] J. O. Christianweber. Differential regulation of b1 and b2 integrin avidity by chemoattractants in eosinophils , 1996 .
[56] R. Coffman,et al. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. , 1990, Proceedings of the National Academy of Sciences of the United States of America.